CONTEXT
A major life sciences organization sought to establish a new, state-of-the-art pharmaceutical manufacturing facility to ramp up localized commercial production. Given the high-stakes nature of biotechnology infrastructure, the project demanded absolute adherence to strict cleanroom parameters, sterile fluid handling systems, and stringent international regulatory standards.

The client's internal leadership team faced major execution bottlenecks mid-flight. They lacked the dedicated project management architecture required to coordinate specialized engineering vendors, manage technical handovers, and clear regulatory validation phases smoothly. To prevent compounding timeline delays and capital waste, they engaged Morgan to instill immediate execution governance.

APPROACH
01 — Defining the Execution Gap: We conducted a thorough structural health check of the active construction and engineering lifecycle. This pinpointed critical scheduling misalignments between facility construction, equipment procurement lines, and regulatory compliance paths.

02 — Integrating Cross-Functional Workstreams: We built a unified master schedule that integrated facility design, equipment qualification (IQ/OQ/PQ), and facility validation. By translating highly complex technical dependencies into clear executive action items, we aligned vendors and stakeholders on an accelerated delivery path.

03 — Operational Readiness & Validation: We deployed a robust framework to transition the facility from a technical project site into a fully operational, live production environment—ensuring plant staff were upskilled and quality management structures were firmly embedded.